What does CUSIP 02155X106 represent in this 13F holders report?

CUSIP 02155X106 is the security identifier for ATHE - ALTERITY THERAPEUTICS LTD - SPONSORED ADR used to aggregate holder disclosures.

How many institutions held ATHE - ALTERITY THERAPEUTICS LTD - SPONSORED ADR in Q2 2021?

10 institutional investors reported ATHE - ALTERITY THERAPEUTICS LTD - SPONSORED ADR for Q2 2021. Use the holders table for investor-level position and value details.

ALTERITY THERAPEUTICS LTD - SPONSORED ADR (ATHE)

CUSIP: 02155X106

Q2 2021 13F Holders as of 30 Jun 2021

Security type / class: Equity / SPONSORED ADR
Total 13F shares: 989,539
Total 13F value: $1,285,108
Share change: -13,880
SEC-reported price per share: $1.30
Number of holders: 10
Value change: -$28,297
Number of buys: 5
Number of sells: 3

Security key

02155X106

Report period

Q2 2021

Institutions

Top holders

ATHE full security history Ownership snapshot Full 13F holder table ALTERITY THERAPEUTICS LTD SEC filings ALTERITY THERAPEUTICS LTD company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ATHE - ALTERITY THERAPEUTICS LTD - SPONSORED ADR (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

MORGAN STANLEY

Disclosed value leader

MORGAN STANLEY

Comparable rows

0/9

Latest evidence

31 Mar 2021

13F Highest disclosed value: $904,000 9 rows are not safely comparable across share classes. Showing 1-6 of 9 holder rows.

Quick read

MORGAN STANLEY has the largest disclosed position value at $904K.

0 of 9 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.

Disclosed position value Top 5

MORGAN STANLEY $904K

RENAISSANCE TECHNOLOGIES LLC $324K

Virtu Financial LLC $101K

CITADEL ADVISORS LLC $94K

GEODE CAPITAL MANAGEMENT, LLC $17K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 9 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
MORGAN STANLEY	13F Company 13F	— denominator unverified	$904,000 627,874 shares	—	31 Mar 2021
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	— denominator unverified	$324,000 224,690 shares	—	31 Mar 2021
Virtu Financial LLC	13F Company 13F	— denominator unverified	$101,000 69,905 shares	—	31 Mar 2021
CITADEL ADVISORS LLC	13F Company 13F	— denominator unverified	$94,000 65,011 shares	—	31 Mar 2021
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$17,000 12,128 shares	—	31 Mar 2021
WELLS FARGO & COMPANY/MN	13F Company 13F	— denominator unverified	$4,000 2,500 shares	—	31 Mar 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

989,539

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 value	Q2 2021 value	Value change	Value Chg %